Astrana Health, Inc. (NASDAQ:ASTH) Stock Rated "Moderate Buy" by Wall Street Analysts

Key Points

• Analysts rate Astrana Health a “Moderate Buy.” Eight of ten analysts recommend buying the stock, while two advise holding it; the average 12-month price target is $49.88 versus a recent price of $37.14.
• Institutional ownership stands at 52.77%. Several funds recently increased or initiated positions, including Fifth Third Bancorp, State of Wyoming and First Citizens Bank & Trust.
• Astrana Health’s latest quarter showed strong growth, with revenue rising 48.5% year over year to $972.52 million and EPS of $0.80, beating estimates of $0.34, although revenue came in slightly below expectations.

Astrana Health, Inc. (NASDAQ:ASTH - Get Free Report) has received an average rating of "Moderate Buy" from the ten brokerages that are covering the stock, Marketbeat.com reports. Two equities research analysts have rated the stock with a hold recommendation and eight have assigned a buy recommendation to the company. The average 1-year price objective among brokerages that have covered the stock in the last year is $49.88.

Several equities analysts recently weighed in on ASTH shares. BTIG Research lifted their target price on Astrana Health from $50.00 to $65.00 and gave the company a "buy" rating in a research report on Tuesday, July 14th. Weiss Ratings reiterated a "hold (c)" rating on shares of Astrana Health in a research note on Thursday, August 27th. Oppenheimer began coverage on shares of Astrana Health in a report on Tuesday, September 15th. They issued an "outperform" rating and a $53.00 target price for the company. Barclays lifted their price target on shares of Astrana Health from $50.00 to $53.00 and gave the company an "overweight" rating in a report on Friday, August 7th. Finally, Wall Street Zen cut shares of Astrana Health from a "buy" rating to a "hold" rating in a research note on Sunday, August 16th.

Institutional Inflows and Outflows

Several hedge funds have recently bought and sold shares of ASTH. Public Employees Retirement System of Ohio bought a new stake in Astrana Health during the second quarter valued at about $51,000. State of Wyoming boosted its stake in shares of Astrana Health by 61.9% in the fourth quarter. State of Wyoming now owns 10,473 shares of the company's stock worth $260,000 after acquiring an additional 4,004 shares during the period. VIRGINIA RETIREMENT SYSTEMS ET Al purchased a new stake in shares of Astrana Health during the second quarter worth about $529,000. Fifth Third Bancorp grew its position in shares of Astrana Health by 4,855.4% during the first quarter. Fifth Third Bancorp now owns 12,438 shares of the company's stock worth $305,000 after purchasing an additional 12,187 shares in the last quarter. Finally, First Citizens Bank & Trust Co. raised its stake in Astrana Health by 48.3% during the 1st quarter. First Citizens Bank & Trust Co. now owns 16,614 shares of the company's stock valued at $407,000 after purchasing an additional 5,408 shares during the period. Institutional investors own 52.77% of the company's stock.

Astrana Health Trading Up 0.4%

Shares of NASDAQ:ASTH opened at $37.14 on Thursday. The stock's 50-day simple moving average is $37.02 and its two-hundred day simple moving average is $36.97. The stock has a market capitalization of $2.07 billion, a price-to-earnings ratio of 45.29 and a beta of 1.03. Astrana Health has a 52-week low of $18.08 and a 52-week high of $51.60. The company has a debt-to-equity ratio of 1.05, a quick ratio of 1.23 and a current ratio of 1.23.

Astrana Health (NASDAQ:ASTH - Get Free Report) last announced its earnings results on Thursday, August 6th. The company reported $0.80 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.34 by $0.46. The company had revenue of $972.52 million during the quarter, compared to analyst estimates of $985.62 million. Astrana Health had a net margin of 1.05% and a return on equity of 10.30%. The firm's quarterly revenue was up 48.5% compared to the same quarter last year. During the same period in the previous year, the business posted $0.19 earnings per share. Analysts expect that Astrana Health will post 1.36 EPS for the current year.

Astrana Health Company Profile

Astrana Health, Inc is a healthcare enablement company that helps physicians and other healthcare providers deliver coordinated, value-based care. The company works with medical groups, independent physician associations and healthcare organizations to manage patient populations, improve clinical outcomes and coordinate services across primary, specialty and post-acute care settings.

Astrana Health provides care-management programs, population-health analytics, technology solutions and administrative support designed to help providers manage risk-based reimbursement arrangements.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.